Detall de la convocatòria

Característiques

Característica
Objectiu de la convocatòria
The goal of the FY19 LCRP is to eradicate deaths and suffering from lung cancer to better the health and welfare of military Service members, Veterans, and the American public. As such, the LCRP will support and integrate research from multiple disciplines for risk assessment, prevention, early detection, diagnosis, and treatment for the control and cure of lung cancer.
Característiques principals
To be considered for funding, applications for the FY19 LCRP Idea Development Award must address at least one of the nine Areas of Emphasis listed below.
  • Identify innovative strategies for the screening and early detection of lung cancer.
  • Understand the molecular mechanisms of initiation and progression to clinically significant lung cancer.
  • Identify innovative strategies for prevention of the occurrence of lung cancer.
  • Identify innovative strategies for the treatment of lung cancer.
  • Identify innovative strategies for the prevention of recurrence of or metastases from lung cancer
  • Develop or optimize predictive markers to assist with therapeutic decision-making.
  • Understand mechanisms of resistance to treatment (primary and secondary).
  • Understand contributors to lung cancer development other than tobacco.
  • Identify innovative strategies for lung cancer care delivery (clinical management/ surveillance/symptom management).

    The LCRP is currently accepting applications for four award mechanisms:
  • Career Development Award: Supports early-career, independent researchers to conduct research under the mentorship of an experienced lung cancer researcher.
  • Idea Development Award: Supports new ideas that are in the early stages of development representing innovative, high-risk/high-gain research. Emphasis is on innovation and impact.
  • Investigator-Initiated Translational Research Award: Supports translational research that will develop promising ideas in lung cancer into clinical applications. Translational research may be defined as an integration of basic science and clinical observations.
  • Translational Research Partnership Award: Supports partnerships between clinicians and research scientists that accelerate ideas in lung cancer into clinical applications. One partner is strongly encouraged to be from a Department of Defense military treatment facility or laboratory, or Veterans Affairs medical center.
    • Lloc de presentació
    El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
    Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.04.00.
    Carol Barnwell: cbarnwell@imim.es Ext.: 1670
    Marta López: mlopez4@imim.es Ext.: 1576
    Convocatòria (URL)
    https://cdmrp.army.mil/funding/lcrp
    Dotació
    Different funding depending on the award mechanism. Please check the Synopsis of PCRP Award Mechanisms or the Program Announcement.
    Documentació
    SUBMISSION INFORMATION:
    All award mechanisms require a Pre-application/Letter of Intent through the electronic Biomedical Research Application Portal (eBRAP) https://ebrap.org/
    Deadline 15 May 2019 (Idea Development Award, Investigator-Initiated Translational Research Award, Translational Research Partnership Award) and August 1st, 209 (Career Development Award)
    Succesfull pre-applications will be invited to submit a full application submission through Grants.gov (http://www.grants.gov/).Deadline August 21, 2019

    Arxius

    Arxiu
    FY19-LCRP-TRPA (1).pdf
    19lcrpreftable (1).pdf
    FY19-LCRP-IITRA (1).pdf
    FY19-LCRP-IDA.pdf
    FY19-LCRP-CDA.pdf
    FY19-LCRP-GAI.pdf